Published in Oncology on January 01, 1983
Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology (2000) 2.58
Morphology of peroneus tertius muscle. Clin Anat (2006) 1.96
Environmental estrogen stimulation of growth and estrogen receptor function in preneoplastic and cancerous human breast cell lines. J Natl Cancer Inst (1997) 1.88
The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol Cell Biochem (1999) 1.44
Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis. Prostate (1999) 1.26
In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treat Rep (1978) 1.15
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant (1998) 1.10
The thyroid gland and its variations: a cadaveric study. Folia Morphol (Warsz) (2010) 1.05
A study of 1126 leukaemia cases--epidemiologic and end result analysis. Indian J Cancer (1979) 1.03
Morphology of the bicipital aponeurosis: a cadaveric study. Folia Morphol (Warsz) (2014) 0.98
Some interesting observations on the surface features of the liver and their clinical implications. Singapore Med J (2009) 0.98
Influence of biomass and gold salt concentration on nanoparticle synthesis by the tropical marine yeast Yarrowia lipolytica NCIM 3589. Colloids Surf B Biointerfaces (2009) 0.96
Extramedullary deposits in acute myelogenous leukaemia. Indian J Cancer (1981) 0.92
Protective effects of antioxidants against smokeless tobacco-induced oxidative stress and modulation of Bcl-2 and p53 genes in human oral keratinocytes. Free Radic Res (2001) 0.89
Cadmium- and chromium-induced oxidative stress, DNA damage, and apoptotic cell death in cultured human chronic myelogenous leukemic K562 cells, promyelocytic leukemic HL-60 cells, and normal human peripheral blood mononuclear cells. J Biochem Mol Toxicol (2000) 0.89
Induced resistance in leukaemia L1210 to adriamycin and its cross-resistance to vincristine and bouvardin. Chemotherapy (1982) 0.88
Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin. Leuk Res (1990) 0.87
In vivo anti-cancer activity of RC-18: a plant isolate from Rubia cordifolia, Linn. against a spectrum of experimental tumour models. Chemotherapy (1982) 0.86
Reverse lectin histochemistry: design and application of glycoligands for detection of cell and tissue lectins. Histol Histopathol (1993) 0.85
A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicol Appl Pharmacol (1997) 0.82
Anti-tumour activity of the extract of Semecarpus anacardium L. nuts in experimental tumor models. Indian J Exp Biol (1980) 0.82
Synthesis, characterization, and cytotoxic studies of alpha-diimine/1,2-diamine platinum(II) and palladium(II) complexes of selenite and tellurite and binding of some of these complexes to DNA. J Inorg Biochem (1991) 0.82
Cell surface properties associated with malignancy of metastatic large cell lymphoma cells. Cancer Res (1987) 0.82
Occurrence of heat-labile Regan type of alkaline phosphatase in hematopoietic tumors. Int J Cancer (1979) 0.82
Anatomy of retrohepatic segment of inferior vena cava and termination of hepatic veins. Indian J Gastroenterol (2010) 0.81
Combination chemotherapy of early and advanced murine P388 leukaemia with bouvardin, cis-diamminedichloroplatinum and vincristine. Oncology (1984) 0.81
Synthesis and spectroscopic studies of potential anticancer [platinum(II)(2,2'-bipyridine)(amino acid)]n+ (n = 1 or 2) complexes. J Inorg Biochem (1985) 0.80
Synthesis, spectroscopic, cytotoxic, and DNA binding studies of binuclear 2,2'-bipyridine-platinum(II) and -palladium(II) complexes of meso-alpha,alpha'-diaminoadipic and meso-alpha,alpha'-diaminosuberic acids. J Inorg Biochem (1992) 0.80
Cell surface alterations in murine leukaemia P388 adriamycin-resistant cells: studies on lectin-induced agglutination and rearrangement of lectin receptors. Oncology (1985) 0.80
Transcultural diabetes nutrition therapy algorithm: the Asian Indian application. Curr Diab Rep (2012) 0.80
Syntheses and spectroscopic studies of potential antitumor copper(II) complexes with 5-phenylazo-3-methoxy salicylidene thiosemicarbazone and N4 substituted thiosemicarbazones. J Inorg Biochem (1989) 0.79
Differentiation inducing effects of butyrate and DMSO on human intestinal tumor cell lines in culture. Cancer Detect Prev (1985) 0.78
In vitro enhancement of adriamycin cytotoxicity in human myeloid leukemia cells exposed to verapamil. Oncology (1984) 0.78
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells. Leuk Lymphoma (2001) 0.78
Synergistic antitumor activity of cisplatin and interleukin 1 in sensitive and resistant solid tumors. Cancer Res (1993) 0.78
Some potential antitumor 2,2'-dipyridylamine Pt(II)/Pd(II) complexes with amino acids: their synthesis, spectroscopy, DNA binding, and cytotoxic studies. J Inorg Biochem (1993) 0.78
Analysis of cell-surface sugar receptor expression by neoglycoenzyme binding and adhesion to plastic-immobilized neoglycoproteins for related weakly and strongly metastatic cell lines of murine tumor model systems. Int J Cancer (1990) 0.78
The immunomodulatory beta-galactoside-specific lectin from mistletoe: partial sequence analysis, cell and tissue binding, and impact on intracellular biosignalling of monocytic leukemia cells. Anticancer Res (1992) 0.77
Pharmacokinetics of methotrexate in Indian children and its relationship to nutritional status. Chemotherapy (1987) 0.77
Combination of antisense oligonucleotide and low-dose chemotherapy in hematological malignancies. J Pharmacol Toxicol Methods (1997) 0.77
2-Hydroxyethylnitrosourea induction of B cell lymphoma in female Swiss mice. Cancer Lett (1990) 0.77
Circumvention of adriamycin resistance: effect of 2-methyl-1,4-naphthoquinone (vitamin K3) on drug cytotoxicity in sensitive and MDR P388 leukemia cells. Cancer Lett (1992) 0.77
Cytotoxicity and DNA binding studies of several platinum (II) and palladium (II) complexes of the 2,2'-bipyridine and an anion of 2-pyridinecarboxylic/2-pyrazinecarboxylic acid. J Inorg Biochem (1992) 0.77
Some mixed-ligand palladium(II) complexes of 2,2'-bipyridine and amino acids as potential anticancer agents. J Inorg Biochem (1985) 0.77
Radiometric evaluation of antibacterial activity of bouvardin (NSC 259968) on Escherichia coli and Staphylococcus aureus. Indian J Exp Biol (1986) 0.77
Some potential anticancer palladium(II) complexes of 2,2'-bipyridine and amino acids. J Inorg Biochem (1986) 0.77
Enhancement of the in vitro cytotoxicity of bouvardin by verapamil alone and combined with hyperthermia in Sarcoma 180 and Ehrlich ascites carcinoma cells. J Cancer Res Clin Oncol (1986) 0.77
Effect of bouvardin (NSC 259968) on the growth characteristics an nucleic acids and protein syntheses profiles of P388 leukemia cells. Chemotherapy (1981) 0.76
Synthesis, characterization, DNA binding, and cytotoxic studies of some mixed-ligand palladium(II) and platinum(II) complexes of alpha-diimine and amino acids. J Inorg Biochem (1991) 0.76
In vivo therapeutic effects of interleukin-12 against highly metastatic residual lymphoma. Clin Exp Metastasis (1996) 0.76
Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. Blood (1995) 0.76
Synthesis, characterization, cytotoxic, and DNA binding studies of some platinum (II) complexes of 1,2-diamine and alpha-diimine with 2-pyridinecarboxylate anion. J Inorg Biochem (1996) 0.76
Pharmacokinetics of methotrexate in adult Indian patients and its relationship to nutritional status. Cancer Treat Rep (1984) 0.76
Macrophage-like-cell-induced growth regulation of lymphoma cells. Oncology (1995) 0.76
Effect of alterations in permeability by nonionic surfactants on adriamycin cytotoxicity in murine tumor models in vitro. Oncology (1990) 0.76
Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). Leukemia (1988) 0.76
Lineage switch in a case of acute lymphoblastic leukemia after twenty six months of remission. Indian J Cancer (1986) 0.76
Enhanced immunosuppressive activity associated with metastatic lymphoma cells. Cancer Res (1993) 0.75
Virulizin-2gamma, a novel immunotherapeutic agent, in treatment of human pancreatic cancer xenografts. Int J Oncol (2000) 0.75
Anti-tumour activity of the methanol extract Ervatamia heyneana (NSC B668619). Indian J Exp Biol (1979) 0.75
Effects of 2,4,5-trichlorophenoxyacetic acid, pentachlorophenol, methylprednisolone, and Freund's adjuvant on 2-hydroxyethylnitrosourea carcinogenesis in MRC-Wistar rats. J Toxicol Environ Health (1991) 0.75
Anti-cancer activity of the extracts of Rubia cordifolia Linn. (NSC b668893). Indian J Exp Biol (1980) 0.75
Restoration of drug sensitivity by nitroxazepine hydrochloride in P388 murine leukemia cells resistant to adriamycin. Cancer Drug Deliv (1987) 0.75
Differential agglutination of P388 adriamycin-sensitive and P388 adriamycin-resistant leukemia cells. Oncology (1983) 0.75
Murine splenocyte migration inhibition assay. II. Characterization of splenic suppressor cells in mice bearing P388/ADR tumor. Neoplasma (1983) 0.75
Modulation of in vitro response to adriamycin by verapamil in murine P388 leukaemia, Ehrlich ascites carcinoma and sarcoma 180. Eur J Cancer Clin Oncol (1987) 0.75
Effect of bouvardin (BVD, NSC 259968) a prospective anti-tumour agent on host immune response in mice. Indian J Exp Biol (1980) 0.75
Reversal of natural resistance to bouvardin (NSC 259968) in sarcoma 180 cells in vitro and in vivo by verapamil. J Cancer Res Clin Oncol (1985) 0.75
Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures. Neoplasma (1986) 0.75
Augmentation of hydroxyurea cytotoxicity by sintamil in human chronic myeloid leukemia cells. Tumori (1986) 0.75
Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone. Oncology (1987) 0.75
Synthesis, spectroscopic, and cytotoxicity studies of some diamine and diimine platinum(II) complexes of diethyldithiocarbamate. J Inorg Biochem (1988) 0.75
Studies on some aspects of the rôle of sulfhydryl groups in morphogenesis. J Embryol Exp Morphol (1965) 0.75
1,10-phenanthroline potentiates cytotoxicity of hydroxyurea in human chronic myeloid leukemia cells. Oncology (1989) 0.75
Studies on high-dose chemotherapy of amygdalin in murine P388 lymphocytic leukaemia and P815 mast cell leukaemia. J Cancer Res Clin Oncol (1985) 0.75
Effect of RC-18, a new anticancer principle isolated from Rubia cordifolia, Linn. on cell cycle of P388 tumour system. Biomed Pharmacother (1982) 0.75
Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro. Neoplasma (1989) 0.75
Alteration in natural resistance of sarcoma 180 tumor to Bouvardin (NSC 259968) following hyperthermia. Tumori (1983) 0.75
In vitro modulation of adriamycin and mitoxantrone cytotoxicity by hyperthermia and diazepam, in human chronic myeloid leukemia cells. Neoplasma (1987) 0.75
Effect of hyperthermia alone and in combination with anticancer drugs on the viability of P388 leukemic cells. Tumori (1984) 0.75
Antitumor effect of L-alanosine (NSC 153553) on sensitive and resistant sublines of murine leukemias. Tumori (1984) 0.75
Effect of vitamin A compounds on DNA biosynthesis in murine tumor models in vitro. Oncology (1987) 0.75
Tumorigenicity and anti-cancer properties of n-hydroxy urethan. Indian J Cancer (1974) 0.75
Anti-cancer activity of the extracts of stem and leaf of Tylophora indica. Indian J Med Res (1972) 0.75
Hyperthermia blocks reversibility of hydroxyurea and bipyridine induced synergistic inhibition of DNA biosynthesis in P388 murine leukemia cells. Neoplasma (1988) 0.75
Effect of Tween 80 on adriamycin cytotoxicity in murine P388 leukemia. Tumori (1984) 0.75
In vitro cytotoxicity of caracemide alone and in combination with hydroxyurea or iron-chelating agents in human chronic myeloid leukemia cells and murine tumors. Neoplasma (1988) 0.75
Toxicological study of Semecarpus anacardium nut extract. Indian J Physiol Pharmacol (1979) 0.75
Potentiation of hydroxyurea cytotoxicity by iron-chelating agent in murine tumor models in vitro. Cancer Drug Deliv (1986) 0.75
Mitoxantrone & adriamycin cytotoxicity enhanced by reserpine in human chronic myeloid leukaemia cells. Indian J Med Res (1989) 0.75
Microbiological assay for antifolate using folic acid assay method. Indian J Cancer (1979) 0.75
Effect of mitoxantrone on human chronic myeloid leukemia cells in vitro, combined with hyperthermia. Neoplasma (1986) 0.75
Potentiation of hydroxyurea cytotoxicity in human chronic myeloid leukemia cells by iron-chelating agent. Leuk Res (1986) 0.75
Biochemical parameters of resistance of an adriamycin-resistant subline of P388 leukemia to emetine, an inhibitor of protein synthesis. J Natl Cancer Inst (1978) 0.75
Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells. Oncology (1989) 0.75